Daniel Steinbach has been the group leader of the molecular biology research laboratory at the Department of Urology, Jena University Hospital, Germany, since 2014. He studied molecular biology at Friedrich Schiller University, Jena, and graduated in 2008 with a diploma. During his doctorate studies, he worked on methylation markers for the prognosis of ovarian carcinoma and the diagnosis of cervical carcinoma. He completed his doctorate (Dr. rer. nat.) with the award of magna cum laude in 2014. In 2015, he received the doctoral thesis award of the Institute of Pathology at the Jena University Hospital. Currently, he is working on molecular mechanisms and markers in the carcinogenesis and progression of urothelial carcinoma. Daniel Steinbach is a member of the German Society for Urology (DGU); a member of the UroFors, natural scientists in the urological research workgroup of the DGU; and a member of the German Research Association for Bladder Cancer e.V. (DFBK).